Trials / Active Not Recruiting
Active Not RecruitingNCT02739711
Glycoprotein IIb/IIIa Inhibitors Versus Standard Therapy in Patients with Myocardial Infarction and No-reflow
Prospective RandomizEd Study Comparing Glycoprotein IIb/IIIa Inhibitors VERsus Standard Therapy in PatientS with Myocardial Infarction and Angiographic Evidence of No-reFLOW
- Status
- Active Not Recruiting
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 120 (estimated)
- Sponsor
- University of Luebeck · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Aim of the study is to examine the effects of glycoprotein IIb/IIIa inhibitors on reperfusion success assessed by cardiac magnetic resonance imaging in patients with myocardial infarction and angiographic evidence of no-reflow.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Glycoprotein IIb/IIIa inhibitors | Glycoprotein IIb/IIIa inhibitors intravenous bolus followed by an intravenous infusion for 12/18 h plus medical standard therapy |
Timeline
- Start date
- 2016-07-01
- Primary completion
- 2024-05-01
- Completion
- 2025-12-01
- First posted
- 2016-04-15
- Last updated
- 2025-01-03
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT02739711. Inclusion in this directory is not an endorsement.